Navigation Links
Biotech Market Trends Study Shows New Competitive Dynamics and Increasing Reimbursement Hurdles
Date:12/9/2011

BETHESDA, Md., Dec. 9, 2011 /PRNewswire-iReach/ -- Novel Health Strategies, LLC, a leading life sciences consulting firm announces the publication of  2010-2011 market trends study called 'What's fueling the biotech engine-2010 to 2011', in Nature Biotechnology. The published article is an analysis of sales, pricing, reimbursement trends and competitive dynamics of more than hundred specialty biologic products. This study highlights several emerging trends in the biotech sector:

Overall market trends:

  • Biotech sector growth outperformed the overall pharmaceutical sector, driven by continued double digit growth in sales of monoclonal antibodies and insulin products. 
  • During the past 12 months, several highly anticipated products reached the market. While some have met expectations, others are facing an uphill battle in gaining acceptance from payers and providers, due to an increased emphasis on controlling healthcare spending and comparative effectiveness.
  • Reimbursement for many of the biologics products is tightening, as more payers are shifting branded products to the specialty tier, increasing the co-pay/co-insurance for patients.
  • New and existing products are facing competition from novel mechanism-of-action small molecules, newer biologics and cheaper products.
  • New challenge for novel therapies is determining the appropriate comparator for pricing of those products. Case studies highlight increasing use of combination and/or sequential therapies, leading to high cost burden for payers and patients.
  • More manufacturers are using cost effectiveness analysis to demonstrate cost savings with their products, however, it is also leading to debate about assumptions and methodologies for such analyses.

Selected sector specific trends:

  • For oncology
    '/>"/>

SOURCE Novel Health Strategies LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
2. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
3. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
4. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
5. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
6. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
7. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
8. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
9. Hawaii Biotech Receives Allowance to Perform West Nile Vaccine Clinical Trials
10. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
11. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  A novel wearable injector slightly larger than an Oreo ... to self-inject prescription drugs in the large doses required to ... autoimmune deficiencies, and genetic disorders.  An emerging ... 2018, according to analysts.   Many of these drugs will require ...
(Date:1/14/2014)... Corporation (Nasdaq: LMNX ) today announced that it ... on Monday, February 3, 2014. A press release announcing the ... (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) Management ... and financial results for the fourth quarter and twelve months ...
(Date:1/14/2014)... The Brandeis Medical Center, led by Dr. Emmanuel Brandeis ... affordable laser tattoo removal experience with the advanced Astanza Duality laser ... high quality cosmetic services with cutting edge medical technology and offering ... California has seen a dramatic increase in the presence ...
Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
... Ultra Clean Holdings, Inc. (Nasdaq: UCTT ), a ... capital equipment, flat panel, medical, energy and research industries will ... October 24, 2011 after markets close. The Company ... results and management,s outlook at 1:45 pm PDT on Monday, ...
... The medical education landscape has changed dramatically ... pressures have reshaped approaches to Continuing Medical Education ... right staffing, investment, and delivery platforms to provide ... To help inform medical education leaders on ...
Cached Medicine Technology:Study Highlights Emerging Approaches to Medical Education in the Pharmaceutical Sector 2
(Date:7/9/2014)... in policing injection drug users in Russia might ... , A study, conducted by researchers from Boston ... collaboration with St. Petersburg Pavlov State University, sought ... the health outcomes of a cohort of HIV-positive ... Those who were arrested by police were more ...
(Date:7/9/2014)... French . By ... including brain structure and function, personality, life experiences and genetics, ... to develop binge drinking within the next two years. Impulsivity, ... as life events and a family history of drug use ... not the child had had a single drink at age ...
(Date:7/9/2014)... extinctions around the world have been linked to ... research from the National Institute for Mathematical and ... may also contribute. , In a series ... causes severe hemorrhage of internal organs in frogs, ... frogs if they are exposed to the virus ...
(Date:7/9/2014)... and Infectious Diseases (NIAID), part of the National ... trial of CRS3123, an investigational oral antibiotic intended ... difficile ) infection. CRS3123 (previously known as REP3123) ... growth while sparing normal intestinal bacteria. , The ... healthy men and women ages 18 to 45 ...
(Date:7/9/2014)... on prescription labels handed out by pharmacists may ... taking medication, according to new research by the ... for the Blind)., The study, published recently in ... labels on prescription medications dispensed by pharmacies do ... , By simply following recommended guidelines for font ...
Breaking Medicine News(10 mins):Health News:BU researchers relate arrests with HIV risk environment 2Health News:What drives a child to abuse alcohol? 2Health News:Study predicts ranavirus as potential new culprit in amphibian extinctions 2Health News:NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection 2Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2
... (HealthDay News) -- The percentage of nursing home residents ... is lower than the national goal, and the rate is ... Brown University researchers examined annual patient records from more ... 2008-09. The overall flu vaccination rate for nursing home ...
... NY, October 5, 2011 -- A possible new target ... the Tyk2 protein helps suppress the growth and metastasis ... Interferon & Cytokine Research , a peer-reviewed journal published ... free online for the next week at http://www.liebertpub.com/jir ...
... mid-infrared laser technologies, such as human breath monitoring, ... environmental health monitoring. The meeting will focus on ... The event is hosted by the NSF Engineering ... the Environment (MIRTHE) headquartered at Princeton University. ...
... News) -- Smokers have heart attacks earlier in life than ... suffer complications after a heart attack, according to a new ... the University of Michigan Medical Center from 1999 through 2006 ... patients were current smokers. Male smokers were nine years ...
... in European Physical Journal E (EPJE), a German ... avoid jamming of soft matter that can be applied in ... at the Institute for Material Physics in Space in Cologne, ... be overcome before a solid material made of a metallic ...
... A team of scientists, led by Johns Hopkins researchers, ... how quickly patients with Alzheimer,s disease (AD) will lose ... compounds in their blood. The finding, they say, could ... also suggest treatment targets for this heartbreaking and incurable ...
Cached Medicine News:Health News:Nursing Homes Not Meeting Flu-Shot Goals, Study Says 2Health News:Unlocking jams in fluid materials 2Health News:Blood tests may hold clues to pace of Alzheimer's disease progression 2
Detection of antibodies to Malaria in Human whole blood....
Paracheck Pf is a two site sandwich immunoassay for the detection of P. falciparum specific histidine rich protein 2 (Pf HRP-2) in whole blood samples....
This is an antigen-capture assay intended for the detection of histidine-rich protein ll (PfHRP-ll), which is released from Malaria-infected red blood cells....
The Malaria Combo Test is a rapid test for the qualitative detection of Plasmodium falciparum and / or Plasmodium vivax , Plasmodium ovale and Plasmodium malariae antigen in whole blood. This ...
Medicine Products: